Your browser doesn't support javascript.
loading
Combination Therapy With Reovirus and Anti-PD-1 Blockade Controls Tumor Growth Through Innate and Adaptive Immune Responses.
Rajani, Karishma; Parrish, Christopher; Kottke, Timothy; Thompson, Jill; Zaidi, Shane; Ilett, Liz; Shim, Kevin G; Diaz, Rosa-Maria; Pandha, Hardev; Harrington, Kevin; Coffey, Matt; Melcher, Alan; Vile, Richard.
Afiliação
  • Rajani K; Department of Molecular Medicine, Mayo Clinic, Rochester, Minnesota, USA.
  • Parrish C; Cancer Research UK Clinical Centre, St. James' University Hospital, Leeds, UK.
  • Kottke T; Department of Molecular Medicine, Mayo Clinic, Rochester, Minnesota, USA.
  • Thompson J; Department of Molecular Medicine, Mayo Clinic, Rochester, Minnesota, USA.
  • Zaidi S; Department of Molecular Medicine, Mayo Clinic, Rochester, Minnesota, USA.
  • Ilett L; Cancer Research UK Clinical Centre, St. James' University Hospital, Leeds, UK.
  • Shim KG; Department of Molecular Medicine, Mayo Clinic, Rochester, Minnesota, USA.
  • Diaz RM; Department of Molecular Medicine, Mayo Clinic, Rochester, Minnesota, USA.
  • Pandha H; University of Surrey, Guildford, UK.
  • Harrington K; The Institute of Cancer Research, London, UK.
  • Coffey M; Oncolytics Biotech Incorporated, Calgary, Alberta, Canada.
  • Melcher A; Cancer Research UK Clinical Centre, St. James' University Hospital, Leeds, UK.
  • Vile R; Department of Molecular Medicine, Mayo Clinic, Rochester, Minnesota, USA.
Mol Ther ; 24(1): 166-74, 2016 Feb.
Article em En | MEDLINE | ID: mdl-26310630

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Reoviridae / Melanoma Experimental / Receptor de Morte Celular Programada 1 / Anticorpos Idioma: En Ano de publicação: 2016 Tipo de documento: Article

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Reoviridae / Melanoma Experimental / Receptor de Morte Celular Programada 1 / Anticorpos Idioma: En Ano de publicação: 2016 Tipo de documento: Article